PRESS RELEASE published on 05/15/2025 at 18:10, 1 year 4 months ago Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli) Viromed Medical AG announces groundbreaking results with cold plasma therapy for ventilator-associated pneumonia (VAP) in an in vitro study. Findings show 100% efficacy against MRSA bacteria without lung cell damage Viromed Medical AG Cold Plasma Therapy Ventilator-associated Pneumonia In Vitro Study VAP
BRIEF published on 04/25/2025 at 12:29, 1 year 5 months ago Viromed Enters European Cosmetics Market with Exclusive ViroCAP® Deal Viromed Medical AG Cold Plasma Technology ViroCAP® My Plasma European Cosmetics Market Landsberg First Class Aesthetic
BRIEF published on 04/25/2025 at 12:29, 1 year 5 months ago Viromed entre sur le marché européen des cosmétiques avec un accord exclusif ViroCAP® Viromed Medical AG Technologie Du Plasma Froid ViroCAP® Mon Plasma Marché Européen Des Cosmétiques Esthétique De Première Classe Landsberg
PRESS RELEASE published on 04/25/2025 at 12:24, 1 year 5 months ago Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market Viromed Medical AG partners with Landsberg First Class Aesthetic to introduce ViroCAP® My Plasma into the European cosmetics market, enhancing aesthetic treatments with cold plasma technology Viromed Medical AG Cold Plasma Technology ViroCAP® My Plasma European Cosmetics Market Landsberg First Class Aesthetic
BRIEF published on 04/23/2025 at 09:10, 1 year 5 months ago Viromed Medical AG Gains New Investor: Dr. Thomas Gutschlag Viromed Medical AG Cold Plasma Technology Medical Investment Thomas Gutschlag CAP Applications
BRIEF published on 04/23/2025 at 09:10, 1 year 5 months ago Viromed Medical AG recrute un nouvel investisseur : le Dr Thomas Gutschlag Viromed Medical AG Investissement Médical Technologie Du Plasma Froid Thomas Gutschlag Demandes De CAP
PRESS RELEASE published on 04/23/2025 at 09:05, 1 year 5 months ago Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor Viromed Medical AG welcomes Dr. Thomas Gutschlag as a new investor, enhancing the company's growth potential with his capital market experience Investor Medical Applications Viromed Medical AG Cold Plasma Technology Dr. Thomas Gutschlag
BRIEF published on 04/10/2025 at 13:55, 1 year 5 months ago Viromed Medical AG Partners with AMAMUS Vet for ViroCAP® VET in Veterinary Medicine Veterinary Medicine Viromed Medical AG Cold Plasma Technology ViroCAP® VET AMAMUS Vet Partnership
BRIEF published on 04/10/2025 at 13:55, 1 year 5 months ago Viromed Medical AG s'associe à AMAMUS Vet pour ViroCAP® VET en médecine vétérinaire Viromed Medical AG Médecine Vétérinaire Technologie Du Plasma Froid ViroCAP® VET Partenariat Vétérinaire AMAMUS
PRESS RELEASE published on 04/10/2025 at 13:50, 1 year 5 months ago Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use Viromed Medical AG partners with Lang Life Sciences GmbH's AMAMUS Vet for exclusive distribution of ViroCAP® VET cold plasma medical device for veterinary use in Germany, Austria, and Switzerland Viromed Medical AG Cold Plasma Technology ViroCAP® VET Lang Life Sciences GmbH AMAMUS Vet
Published on 10/09/2026 at 14:00, 7 hours 39 minutes ago Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 7 hours 39 minutes ago Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 8 hours 16 minutes ago SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 8 hours 39 minutes ago Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 8 hours 39 minutes ago Nepra Foods Launches Flagship PROPASTA Brand on Amazon
Published on 10/09/2026 at 21:24, 14 minutes ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 21 minutes ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:22, 2 hours 17 minutes ago EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Published on 10/09/2026 at 18:00, 3 hours 39 minutes ago ARVERNE GROUP: Arverne franchit une étape majeure : l'Europe fait du projet Lithium de France un pilier de sa souveraineté industrielle
Published on 10/09/2026 at 19:27, 2 hours 11 minutes ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 2 hours 11 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 3 hours 54 minutes ago Déclaration des droits de vote à fin septembre 2026